Skip to main content
Premium Trial:

Request an Annual Quote

Michael Wyzga

Exact Sciences has increased the size of its board to 10 directors and appointed Michael Wyzga to fill the spot. Wyzga will serve as a Class III director and be on Exact's audit committee until the firm's 2015 annual meeting. Between 2011 and 2013, he was the president and CEO of Radius Health, where he was also a board member. Prior to that, he held various management positions at Genzyme. Wyzga currently is a director at Akebia Therapeutics and Oncomed Pharmaceuticals.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.